Publications by authors named "Liangzhu Quan"
Cerebral biomimetic nano-drug delivery systems: A frontier strategy for immunotherapy.
J Control Release
December 2024
Brain diseases are a significant threat to human health, especially in the elderly, and this problem is growing as the aging population increases. Efficient brain-targeted drug delivery has been the greatest challenge in treating brain disorders due to the unique immune environment of the brain, including the blood-brain barrier (BBB). Recently, cerebral biomimetic nano-drug delivery systems (CBNDSs) have provided a promising strategy for brain targeting by mimicking natural biological materials.
View Article and Find Full Text PDFArticle Synopsis
- Bacterial infections are common, and while antibiotics have been crucial in treating them, increasing drug resistance is now a significant threat to public health.
- Recent studies focus on innovative methods to combat this resistance, including new antimicrobial materials and advanced drug delivery systems, particularly nanotechnology.
- The review discusses different strategies to tackle drug-resistant bacteria, highlights recent advancements, and addresses the challenges and future directions in developing effective solutions.
Gout is one of the most prevalent rheumatic diseases, globally. Colchicine (COL) is the first-line drug used for the treatment of acute gout. However, the oral administration of COL is restricted, owing to serious adverse reactions.
View Article and Find Full Text PDF